Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Protective mucus coatings typically trap and rapidly remove foreign particles from the eyes, gastrointestinal tract, airways, nasopharynx, and female reproductive tract, thereby strongly limiting opportunities for controlled drug delivery at mucosal surfaces. No synthetic drug delivery system composed of biodegradable polymers has been shown to penetrate highly viscoelastic human mucus, such as non-ovulatory cervicovaginal mucus, at a significant rate. We prepared nanoparticles composed of a biodegradable diblock copolymer of poly(sebacic acid) and poly(ethylene glycol) (PSA-PEG), both of which are routinely used in humans. In fresh undiluted human cervicovaginal mucus (CVM), which has a bulk viscosity approximately 1,800-fold higher than water at low shear, PSA-PEG nanoparticles diffused at an average speed only 12-fold lower than the same particles in pure water. In contrast, similarly sized biodegradable nanoparticles composed of PSA or poly(lactic-co-glycolic acid) (PLGA) diffused at least 3,300-fold slower in CVM than in water. PSA-PEG particles also rapidly penetrated sputum expectorated from the lungs of patients with cystic fibrosis, a disease characterized by hyperviscoelastic mucus secretions. Rapid nanoparticle transport in mucus is made possible by the efficient partitioning of PEG to the particle surface during formulation. Biodegradable polymeric nanoparticles capable of overcoming human mucus barriers and providing sustained drug release open significant opportunities for improved drug and gene delivery at mucosal surfaces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral application of OVA-loaded PLGA nanospheres, which were further coated with PEG to reduce particle aggregation and to enhance particulate blood circulation [78], initiated a high OVA-specific IgG response at very low allergen amounts (5 μg).”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Designing materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198 · cited 1×
“In addition to rapid penetration of mucus fluids, important attributes of a desirable polymeric platform for mucosal drug delivery include efficient drug loading and sustained release upon exposure to water (41).”
BackgroundBiodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815 · cited 5×
“Encapsulation of drugs and genes in polymeric particles offers the potential for localized and sustained delivery to mucosal tissues (1, 2).”
BackgroundSelf-citationTargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663 · cited 1×
“Using these polymers, we formulated nanoparticles with an average hydrodynamic diameter of 173 nm (Table 1) using a conventional solvent diffusion method where the continuous phase was water (19).”
MethodMicro- and macrorheology of mucus
Lai, S. K., Wang, Y.-Y., Wirtz, D., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.012 · Cited by 1,223 · cited 1×
“We further tested the ability of biodegradable PSA-PEG particles to penetrate fresh, undiluted sputum expectorated from cystic fibrosis (CF) patients, which has a bulk viscosity typically approximately 104- to 105-fold higher than that of water under low shear (compared to 103-fold for mucus from healthy volunteers) (…”
BackgroundSelf-citationMatsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,169 · cited 1×
“By using the Fick diffusion model and a sputum layer thickness of approximately 10 m (the thickness of sputum is decreased due to dehydration of airway mucus secretions and collapse of the periciliary layer from the imbalanced ion transport in CF) (26), we again expect significant fractions of biodegradable PSA-PEG na…”
MethodMucus clearance as a primary innate defense mechanism for mammalian airways
Knowles, M. R., & Boucher, R. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215217 · Cited by 1,054 · cited 1×
“The reported diffusion coefficient for latex nanoparticles ranging in size from 59–1,000 nm is 0 m2/s in human cervical mucus (7); particles trapped in this manner are typically cleared from mucosal surfaces within seconds to a few hours depending on anatomical site (3, 8, 9).”
BackgroundRapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050 · cited 10×
“We have recently discovered that densely coating nonbiodegradable latex particles with PEG, a hydrophilic and uncharged molecule, effectively minimizes adhesive interactions between nanoparticles and mucins (13), thereby allowing nanoparticles to rapidly penetrate highly viscoelastic human mucus by moving through open…”
BackgroundMethodResultSelf-citationBiologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Single-particle tracking: the distribution of diffusion coefficients
Saxton, M. J. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78820-9 · Cited by 603 · cited 1×
“The extent of impediment to particle motion can be determined by fitting MSD to the equation, MSD 4Do , where Do is the time scaleindependent diffusion coefficient, is the time scale, and ranges from 0 (completely immobile particles) to 1 (unobstructed Brownian diffusion, such as that of particles in water) (13, 21).”
BackgroundWang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R., & Hanes, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597 · cited 8×
“We recently found that as little as a 40% reduction in PEG density ( 60,000 PEG molecules per 200 nm latex particle) can reduce nanoparticle transport rates by nearly 1,000-fold in CVM (14).”
BackgroundMethodResultSelf-citationDeposition, retention, and clearance of inhaled particles.
Lippmann, M., Yeates, D. B., & Albert, R. E. (1980) · Occupational and Environmental Medicine · doi:10.1136/oem.37.4.337 · Cited by 557 · cited 1×
“The reported diffusion coefficient for latex nanoparticles ranging in size from 59–1,000 nm is 0 m2/s in human cervical mucus (7); particles trapped in this manner are typically cleared from mucosal surfaces within seconds to a few hours depending on anatomical site (3, 8, 9).”
BackgroundDiffusion of Macromolecules and Virus-Like Particles in Human Cervical Mucus
Olmsted, S. S., Padgett, J. L., Yudin, A. I., Whaley, K. J., Moench, T. R., & Cone, R. A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75844-4 · Cited by 544 · cited 2×
“Highly viscoelastic mucus secretions usually adhere to, wrap up, and efficiently immobilize nanoparticles, including some previous attempts with biodegradable PEG-coated systems (2, 7).”
BackgroundKumar, N., Langer, R. S., & Domb, A. J. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00050-9 · Cited by 394 · cited 1×
“We sought to address these requirements by using PSA, a member of the polyanhydride family that offers well-controlled continuous release kinetics (with little to no initial burst) for many drugs (42), as the core material of the particles.”
MethodBehrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372 · cited 1×
“Discussion PEG coatings have been widely used in the development of polymeric drug carriers, including particles composed of biodegradable polyesters (27, 28) and polyanhydrides (29–32).”
BackgroundSuk, J. S., Lai, S. K., Wang, Y.-Y., Ensign, L. M., Zeitlin, P. L., Boyle, M. P., & Hanes, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.076 · Cited by 352 · cited 3×
“Cystic fibrosis sputum was collected as previously described (1, 16).”
BackgroundMethodSelf-citationDawson, M., Wirtz, D., & Hanes, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309026200 · Cited by 316 · cited 3×
“Cystic fibrosis sputum was collected as previously described (1, 16).”
BackgroundMethodSelf-citationCleland, J. L., Lam, X., Kendrick, B., Yang, J., Yang, T., Overcashier, D., Brooks, D., Hsu, C., & Carpenter, J. F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200103)90:3<310::aid-jps6>3.0.co;2-r · Cited by 299
Airway Mucus: From Production to Secretion
Williams, O. W., Sharafkhaneh, A., Kim, V., Dickey, B. F., & Evans, C. M. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0436sf · Cited by 284
Real-time multiple-particle tracking: applications to drug and gene delivery
Suh, J., Dawson, M., & Hanes, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.06.001 · Cited by 274 · cited 1×
“We next studied, using high-resolution multiple particle tracking (1, 13, 20), the transport rates in mucus of nanoparticles composed of PSA-PEG as compared to those composed of conventional biodegradable polymers, PSA and PLGA.”
MethodSelf-citationCu, Y., & Saltzman, W. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8001254 · Cited by 267 · cited 11×
“This is consistent with the rapid migra- tion of sperm and motile bacteria across OCM but not CVM (39, 40).”
BackgroundResultInfluentialRole of airway surface liquid and submucosal glands in cystic fibrosis lung disease
Verkman, A. S., Song, Y., & Thiagarajah, J. R. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00417.2002 · Cited by 230 · cited 1×
“In the lung, estimates for the thickness of the luminal mucus gel range from 7- m in the deep airways to 55- m in the bronchi (23).”
BackgroundBiodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release
Yoo, H. S., Oh, J. E., Lee, K. H., & Park, T. G. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908421434 · Cited by 225 · cited 1×
“PLGA was purchased from Alkermes, fluorescently labeled as previously described (46), and formulated into nanoparticles using the same process.”
MethodThe Expanding Role of Aerosols in Systemic Drug Delivery, Gene Therapy, and Vaccination
Laube, B. L. (2005) · Respiratory Care · doi:10.4187/respcare.05501161 · Cited by 176
New polymeric carriers for controlled drug delivery following inhalation or injection
Fu, J., Fiegel, J., Krauland, E., & Hanes, J. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00182-5 · Cited by 163 · cited 2×
“It is noteworthy that particles composed of random copolymers of PSA and PEG, the subject of previous reports by our group (37, 38), were strongly immobilized in human mucus, likely due to insufficient freedom of the PEG chains to partition to the particle surface when they are flanked on both ends by PSA segments (i.”
BackgroundMethodSelf-citationAltering Mucus Rheology to “Solidify” Human Mucus at the Nanoscale
Lai, S. K., Wang, Y.-Y., Cone, R., Wirtz, D., & Hanes, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004294 · Cited by 151 · cited 2×
“05) have thus far been limited to non-degradable latex particles (13, 14, 16, 17).”
BackgroundSelf-citationYoncheva, K., Lizarraga, E., & Irache, J. M. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.12.002 · Cited by 145
Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus
Dawson, M., Krauland, E., Wirtz, D., & Hanes, J. (2004) · Biotechnology Progress · doi:10.1021/bp0342553 · Cited by 142 · cited 2×
“showed that biodegradable PLGA nanoparticles coated with DNA moved approximately 10-fold faster in reconstituted bovine gastric mucus than similar-sized latex particles (45).”
BackgroundMethodSelf-citationMucus altering agents as adjuncts for nonviral gene transfer to airway epithelium
Ferrari, S., Kitson, C., Farley, R., Steel, R. M., Marriott, C., Parkins, D., Scarpa, M., Wainwright, B. J., Evans, M., Colledge, W. H., et al. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301525 · Cited by 120
Usselman, M. C., & Cone, R. A. (1983) · Biology of Reproduction · doi:10.1095/biolreprod29.5.1241 · Cited by 116 · cited 1×
“This is consistent with the rapid migration of sperm and motile bacteria across OCM but not CVM (39, 40).”
BackgroundThe Amount of MUC5B Mucin in Cervical Mucus Peaks at Midcycle1
Gipson, I. K., Moccia, R., Spurr-Michaud, S. J., Argüeso, P., Gargiulo, A., Hill, J. A., Offner, G. D., & Keutmann, H. T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7174 · Cited by 105
Fresta, M., Fontana, G., Bucolo, C., Cavallaro, G., Giammona, G., & Puglisi, G. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200103)90:3<288::aid-jps4>3.0.co;2-5 · Cited by 99 · cited 1×
“Discussion PEG coatings have been widely used in the development of polymeric drug carriers, including particles composed of biodegradable polyesters (27, 28) and polyanhydrides (29–32).”
BackgroundThe Amount of MUC5B Mucin in Cervical Mucus Peaks at Midcycle
Gipson, I. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.594 · Cited by 88
Stealth particles give mucus the slip
Cu, Y., & Saltzman, W. M. (2009) · Nature Materials · doi:10.1038/nmat2347 · Cited by 82 · cited 2×
“Since particles that are immobilized by mucus barriers are typically efficiently cleared from the mucosal tissue, the design of biodegradable mucus-penetrating nanoparticle systems capable of sustained drug or nucleic acid delivery has become a priority for the improved treatment of numerous diseases that affect mucos…”
BackgroundPoly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs
Fiegel, J., Fu, J., & Hanes, J. S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.018 · Cited by 80 · cited 1×
“It is noteworthy that particles composed of random copolymers of PSA and PEG, the subject of previous reports by our group (37, 38), were strongly immobilized in human mucus, likely due to insufficient freedom of the PEG chains to partition to the particle surface when they are flanked on both ends by PSA segments (i.”
BackgroundSelf-citationYoncheva, K., Guembe, L., Campanero, M. A., & Irache, J. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.016 · Cited by 62
Quantifying the intracellular transport of viral and nonviral gene vectors in primary neurons.
Suk, J. S., Suh, J., Lai, S. K., & Hanes, J. S. (2007) · PubMed · Cited by 60
Self-citationA Self-Sampling Method to Obtain Large Volumes of Undiluted Cervicovaginal Secretions
BOSKEY, E. R., MOENCH, T. R., HEES, P. S., & CONE, R. A. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200302000-00002 · Cited by 59 · cited 1×
“Cervicovaginal mucus was collected and prepared as previously described (13, 47).”
MethodFu, J., Fiegel, J., & Hanes, J. S. (2004) · Macromolecules · doi:10.1021/ma049853s · Cited by 53
Self-citationPharmaceutical and biotechnological aerosols for cystic fibrosis therapy
Garcia‐Contreras, L., & Hickey, A. J. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00159-x · Cited by 51
Tang, B. C., Fu, J., Watkins, D. N., & Hanes, J. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.033 · Cited by 41
Self-citationLay, J. C., Stang, M. R., Fisher, P. E., Yankaskas, J. R., & Bennett, W. D. (2003) · Journal of Aerosol Medicine · doi:10.1089/089426803321919915 · Cited by 33
Yoncheva, K., Centelles, M. N., & Irache, J. M. (2008) · Journal of Microencapsulation · doi:10.1080/02652040701776083 · Cited by 19
Effect of reproductive status on uptake of latex microparticles in rat small intestine
Smyth, S. H., Doyle-McCullough, M., Cox, Ó. T., & Carr, K. E. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.030 · Cited by 17
Research works printed but not linked: 1
- RA Cone, Mucus. Mucosal Immunology, eds PL Ogra, ME Lamm, W Strober, JR McGhee, J Mestecky, J Bienenstock (Academic, 3 Ed, San Diego), pp. 43–64 (1999).
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
“Importantly, numerous methods for producing biodegradable NPs with sufficiently dense PEG coatings for rapid penetration through human CVM have been described [133, 136-138], providing an array of options for developing NP-based therapies for more efficacious vaginal drug delivery.”
Self-citationBiomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
“However, there are many other PEGylated polymers for making drug-containing NPs, including polylactic acid [79], poly(hexadecylcyanoacrylate) (PHDCA) [21], polycaprolactone [80], chitosan [81] and poly(sebacic acid) [82].”
BackgroundOral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
“This mucoinert coating has been translated to engineering biodegradable nanoparticles [8], nanoparticles capable of penetrating highly viscoelastic cystic fibrosis sputum [7], and biodegradable particles composed entirely of “generally regarded as safe” (GRAS) ingredients [10].”
BackgroundSelf-citationAnselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
“Interestingly, recent preclinical work has highlighted advantages of PEGylated particles beyond extended circulation, notably their diffusion in tissues(118) and their abilities to pass through tight biological barriers.(36,119) It is possible that clinically used PEGylated particles have benefitted from these effects.”
Background
Metadata
- Authors
- Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J.
- Affiliations
- Johns Hopkins University (US)
- Georgia Institute of Technology (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-11-17
- Volume
- 106
- Issue
- 46
- Pages
- 19268-19273
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2780804
- OpenAlex
- W2071026997
- Cited by
- 453
- References
- 47
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 16 · 2023: 22 · 2022: 20 · 2021: 25 · 2020: 31 · 2019: 26 · 2018: 33 · 2017: 40 · 2016: 33 · 2015: 31 · 2014: 35 · 2013: 29 · 2012: 33
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R21HL089816)
- National Cancer Institute (R01CA140746)
- National Center for Research Resources (UL1RR025005)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- mucus penetration, biodegradable polymer nanoparticles, cervicovaginal mucus, polyethylene glycol, poly(lactic-co-glycolic acid), mucus viscosity, nanoparticle diffusion, sputum, cystic fibrosis, mucosal drug delivery, sustained drug release
- MeSH terms
- Anhydrides, Cervix Mucus, Cystic Fibrosis, Drug Carriers, Female, Humans, Polyethylene Glycols, Sputum, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.